Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
MON
Monsanto Co
MON
|
$224M |
| 2 |
Verizon
VZ
|
$176M |
| 3 |
CERN
Cerner Corp
CERN
|
$173M |
| 4 |
NetApp
NTAP
|
$165M |
| 5 |
Merck
MRK
|
$152M |
Top Sells
| 1 |
Air Products & Chemicals
APD
|
$169M |
| 2 |
Darden Restaurants
DRI
|
$112M |
| 3 |
Oracle
ORCL
|
$95.5M |
| 4 |
Truist Financial
TFC
|
$78.9M |
| 5 |
Tapestry
TPR
|
$76.9M |
Sector Composition
| 1 | Healthcare | 15.32% |
| 2 | Financials | 11.03% |
| 3 | Technology | 10.96% |
| 4 | Energy | 9.88% |
| 5 | Industrials | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.77T
| $1.09B | 2.64% | 23,411,157 +203,100 | +0.9% | +$9.42M |
|
2
Texas Instruments
TXN
$184B
| $997M | 2.43% | 20,904,569 -491,480 | -2% | -$23.4M |
|
3
Gilead Sciences
GILD
$140B
| $992M | 2.42% | 9,320,100 -614,400 | -6% | -$65.4M |
|
4
Chevron
CVX
$324B
| $957M | 2.33% | 8,019,795 +1,149,685 | +17% | +$137M |
|
|
5
Verizon
VZ
$186B
| $842M | 2.05% | 16,849,748 +3,515,510 | +26% | +$176M |
|
|
6
Merck
MRK
$210B
| $804M | 1.96% | 13,570,360 +2,568,030 | +23% | +$152M |
|
7
Home Depot
HD
$405B
| $763M | 1.86% | 8,314,002 -288,500 | -3% | -$26.5M |
|
8
Bristol-Myers Squibb
BMY
$96B
| $760M | 1.85% | 14,847,410 +954,460 | +7% | +$48.8M |
|
9
AbbVie
ABBV
$372B
| $752M | 1.83% | 13,024,695 -1,255,330 | -9% | -$72.5M |
|
10
ConocoPhillips
COP
$124B
| $751M | 1.83% | 9,814,615 +514,825 | +6% | +$39.4M |
|
11
Coca-Cola
KO
$297B
| $710M | 1.73% | 16,650,470 +1,417,620 | +9% | +$60.5M |
|
12
DuPont de Nemours
DD
$32.2B
| $658M | 1.6% | 12,544,327 +4,490 | +0% | +$235K |
|
13
Procter & Gamble
PG
$368B
| $600M | 1.46% | 7,159,565 +184,975 | +3% | +$15.5M |
|
14
Newell Brands
NWL
$2.48B
| $509M | 1.24% | 14,796,500 +2,795,700 | +23% | +$96.2M |
|
15
Pfizer
PFE
$141B
| $508M | 1.24% | 17,167,701 +12,550 | +0.1% | +$371K |
|
16
Wells Fargo
WFC
$263B
| $493M | 1.2% | 9,504,000 +1,129,900 | +13% | +$58.6M |
|
|
17
Oracle
ORCL
$635B
| $467M | 1.14% | 12,195,900 -2,495,600 | -17% | -$95.5M |
|
18
Goldman Sachs
GS
$226B
| $455M | 1.11% | 2,476,300 +277,200 | +13% | +$50.9M |
|
19
Enbridge
ENB
$105B
| $449M | 1.09% | 9,378,070 +798,040 | +9% | +$38.2M |
|
20
Duke Energy
DUK
$95.3B
| $445M | 1.08% | 5,946,972 +3,370 | +0.1% | +$252K |
|
21
Marsh & McLennan
MMC
$101B
| $429M | 1.05% | 8,198,194 +637,000 | +8% | +$33.3M |
|
22
Schlumberger
SLB
$55B
| $427M | 1.04% | 4,197,400 +100,000 | +2% | +$10.2M |
|
|
MON
23
DELISTED
Monsanto Co
MON
| $419M | 1.02% | 3,723,300 +1,989,400 | +115% | +$224M |
|
24
Amgen
AMGN
$155B
| $397M | 0.97% | 2,828,248 | – | – |
|
25
JPMorgan Chase
JPM
$829B
| $396M | 0.96% | 6,567,700 +180,300 | +3% | +$10.9M |
|